About 1 200 reports

  • Increase in chronic diseases
  • Stringent regulatory guidelines

About Coronary Artery Disease Therapeutics Coronary artery disease (CAD) is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries...

  • Chronic Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Increasing prevalence of chronic diseases
  • Market definition

About Wearable Medical Devices Wearable medical devices are defined as devices with sensors that are worn by a person. These devices detect and monitor changes in body signatures of various areas and organs. Technavio’s analysts forecast the global wearable medical devices market to grow at a CAGR of 9.82% during...

  • Chronic Disease
  • Fitbit, Inc.
  • Garmin Ltd.
  • Omron Corporation
  • Sonova Holding AG
  • Rise in Prevalence of Chronic Diseases
  • Syringe Market: Revenue Forecast in USD million, Australia, 2015-2023

The global syringe market is expected to witness robust growth owing to several factors such as rise in demand for pre-filled syringes, growing prevalence of chronic diseases such as diabetes, increase in usage of Botox for therapeutic applications. Moreover, the growing number of vaccination and immunization programs are expected to drive...

  • Chronic Disease
  • B. Braun Melsungen AG
  • Catalent Pharma Solutions, Inc.
  • Gerresheimer AG
  • Terumo Corporation
  • INCREASING HEALTH EXPENDITURE, COUPLED WITH HIGH PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO RISE THE DEMAND OF
  • FACTORS SUCH AS RAPID URBANIZATION, AGED POPULATION, PREVALENCE OF CHRONIC DISEASES, INCREASING POPULATION, RISING

Executive Summary Over the recent years, the global nutraceuticals industry has been growing rapidly as the global sales of Functional Beverages, Functional Food and Dietary Supplements have been witnessing rapid growth. According to Azoth Analytics research report, “Global Nutraceuticals Market - Analysis By Type (Functional...

  • Chronic Disease
  • World
  • Market Size
  • Amway Corporation
  • DuPont
  • Increase in chronic diseases
  • MEDIUM

About Heart Failure Drugs The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major...

  • Beta-Blocker
  • Chronic Disease
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG
  • Increase in chronic diseases
  • HIGH

About Angina Pectoris Drugs Angina is a type of chest pain or discomfort caused due to a coronary heart disease, specifically due to reduced blood flow to the heart. For angina pectoris drugs market, beta blockers remain the most preferred line of treatment. However, the treatment market witnesses a strong presence of other drug...

  • Beta-Blocker
  • Chronic Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • chronic diseases is foreseen to support the market for sterile Injectable.
  • There is a direct correlation between old age and occurrence of chronic disease such as diabetes, cardiac respiratory disorders,.

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Sterile Injectables Market by Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody,...

  • Chronic Disease
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • CHINA DALYS OF CHRONIC DISEASE
  • CHINA DALYS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2013-2016 %)

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Medical Glove Market by Product Type (Surgical, Examination, Others), By Raw Material Type (Latex,...

  • Chronic Disease
  • World
  • Market Size
  • Ansell Limited
  • Top Glove Corporation Bhd
  • RISING PREVALENCE OF CHRONIC DISEASES
  • Impact of drivers

About Hypercholesterolemia Hypercholesterolemia is characterized by high levels of total cholesterol and LDL-C in the blood. High cholesterol levels can cause CVDs such as stroke and atherosclerosis. The typical range of total blood cholesterol is 140-200 mg/dL.Blood cholesterol contains individual components such as LDL-C and HDL-C....

  • Chronic Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • NUMBER OF CITIZEN 65 YEARS AND ABOVE, USA AND CANADA IN MILLION 2016
  • North America Bio CMO Market

Additionally, surging number of patients with chronic diseases is further propelling the growth of manufacturers in the region is one of the major factor driving the growth of Bio CMO industries.

  • Chronic Disease
  • North America
  • World
  • Market Size
  • Lonza Group Ltd
  • CHRONIC DISEASES SEGMENT TO COMMAND THE LARGEST SHARE OF THE
  • PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2015-2022 (USD MILLION)

“Patient engagement solutions market is projected to register a CAGR of 16.2%” The global patient engagement solutions market is estimated to register a CAGR of 16.2% from 2017 to 2022, to reach USD 18.68 billion. The key factors driving the growth of the overall patient engagement solutions market include the rise in aging population,...

  • Chronic Disease
  • North America
  • United States
  • Cerner Corporation
  • GetWellNetwork, Inc.
  • THE MICROBIOME AND CHRONIC DISEASE
  • THE MICROBIOME AND CHRONIC DISEASE

Chronic diseases are going to create a new leverage point for probiotic products, especially in the area of cardiovascular health and diabetes. Part two of this global briefing on probiotics aims to highlight where future growth in probiotics is to be found. It also reviews the regulatory status and shows how both permitting and banning health...

  • Chronic Disease
  • European Union
  • United States
  • World
  • Demand
  • A NEW WAY TO HELP MANAGE THE HUGE AND GROWING BURDEN OF TREATING CHRONIC DISEASES
  • DEVICES AND APPS THAT CAN GATHER DATA ABOUT PATIENT BEHAVIOR AND HELP MANAGE CHRONIC DISEASES

ForeSights: Digiceuticals Summary Digiceuticals are computer software, smartphones, digital services, and so on with the potential to improve health outcomes as much as drugs can. Digiceuticals reside at the intersection of medicine and digital health technology and have the potential to increase medication compliance...

  • Chronic Disease
  • Pathology
  • World
  • Demand

SUPPLIER POWER - LOW ##.

  • Chronic Disease
  • Diabetes
  • North America
  • World
  • Market Size
  • GLOBAL OXYGEN THERAPY EQUIPMENT MARKET DRIVERS
  • POPULATION AGED 65 & ABOVE, 2012- 2016 (% OF TOTAL POPULATION)

Increase in the ageing population of the world is one of the biggest driver of the global durable medical equipment as the older population is more vulnerable to suffering from chronic disease.

  • Chronic Disease
  • Medical Device
  • Medical Equipment
  • World
  • Market Size
  • Increasing incidence of chronic diseases and rise in geriatric population
  • Individuals

About Home-care Monitoring and Diagnostics Home-care diagnostics and monitoring devices refer to a wide range of medical products (including heart rate monitors, blood glucose level indicators, and nebulizers), and services, that provide health monitoring, treatment, and physical support to individuals. People need not visit a hospital...

  • Chronic Disease
  • World
  • Johnson & Johnson
  • Medtronic, Inc.
  • Omron Corporation
  • Generally, it is a chronic condition with bouts of worsening symptoms that requires medical
  • shows New York Heart Association (NYHA) classification system. Patients are separated

Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy Summary Heart failure (HF) is a life-threatening syndrome with substantial morbidity and mortality. There are more than 26 million people with...

  • Chronic Disease
  • World
  • Market Size
  • Bristol-Myers Squibb Company
  • Les Laboratoires Servier SAS
  • Identifying factors impacting market growth
  • MARKET OUTLINE

One reason for the rise in life expectancy is due to the shift in the cause of death from acute to chronic diseases such as diabetes, arthritis, high cholesterol, and hypertension.

  • Chronic Disease
  • World
  • Demand
  • Forecast
  • Market Size
  • LEGAL
  • INFORMATION ON THE LEADING COMPANIES IN THIS MARKET IS GIVEN BELOW.

The Business Research Company The Business Research Company July 2018 February 2018 Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ##

  • Chronic Disease
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Data
  • DRIVERS OF THE MARKET

it em =U GF yZW##SUQ## MzgyNzg##fENoa WxkSUQ##L TF## VHlwZ T##z& t= ## & cb=## ## ## ## ## http:/ / ww w. abbottinve stor. c om/ phoenix. zhtml?

  • Chronic Disease
  • Diabetes
  • Diabetes Care
  • Diabetes Monitoring
  • Medical Device
  • Rise in chronic diseases
  • Rise in chronic diseases

About Dual Energy X-ray Absorptiometry DEXA is a means of measuring bone mineral density (BMD) quickly and accurately for examining individuals at risk of osteoporosis and in helping clinicians’ recommend the appropriate fracture treatment. Technavio’s analysts forecast the global dual energy X-ray absorptiometry...

  • Chronic Disease
  • Pathology
  • World
  • Hitachi, Ltd.
  • Hologic, Inc.
  • ENVIRONMENTAL
  • Information on the leading companies in this market is given below.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Chronic Disease
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028 ##.

  • Chronic Disease
  • Pathology
  • World
  • Forecast
  • Market Shares
  • DIAGNOSTIC CATHETERS MARKET IN APAC

The prevalence of chronic diseases has been increasing at a higher rate in the region.

  • Chronic Disease
  • Abbott
  • Boston Scientific Corporation
  • Cordis Corporation
  • Jude Medical, Inc.
  • GLOSSARY OF TERMS
  • 3.1 OVERVIEW

Diabetes is one of the chronic diseases prevalent in the UAE.

  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • Insulet Corporation
  • GLAXOSMITHKLINE

Development Of RMC-## Drug For Respiratory Diseases Treatment - The development of the RMC-## drug has enabled the blocking of the series of chain reactions that result in respiratory diseases such as asthma and COPD.

  • Chronic Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • INORGANIC GROWTH STRATEGIES
  • MARKET CHALLENGES

Impact: ## Low; ## High F.

  • Chronic Disease
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • MedImmune, LLC
  • Pfizer Inc.
  • Rise in chronic diseases demand safe administration of medication
  • Top 3 countries in Americas

About Needle-Free IV Connectors Needle-free IV connectors are used to connect administration sets, syringes, and IV catheters. Technavio’s analysts forecast the global needle-free IV connectors market to grow at a CAGR of 9.56% during the period 2018-2022. Covered in this report The...

  • Chronic Disease
  • Hospital
  • Injectable Delivery
  • B. Braun Medical
  • Baxter International Inc.
  • Barriers
  • 2.3 LOW DIAGNOSIS RATES AND COMPLIANCE LEAVE KEY UNMET NEEDS IN THE

This is linked to the second problem, that is represented by the fact that osteoporosis is a chronic disease.

  • Chronic Disease
  • United States
  • World
  • Amgen Inc.
  • Eli Lilly & Co.